These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1402 related articles for article (PubMed ID: 9360506)

  • 21. Natural history, treatment, and course of papillary thyroid carcinoma.
    DeGroot LJ; Kaplan EL; McCormick M; Straus FH
    J Clin Endocrinol Metab; 1990 Aug; 71(2):414-24. PubMed ID: 2380337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Papillary thyroid carcinoma: factors influencing recurrence and survival.
    Toniato A; Boschin I; Casara D; Mazzarotto R; Rubello D; Pelizzo M
    Ann Surg Oncol; 2008 May; 15(5):1518-22. PubMed ID: 18324441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrence factors and prevention of complications of pediatric differentiated thyroid cancer.
    Wang C; Chen X; Wei X; Chen F; Wang Y; Shen Z
    Asian J Surg; 2017 Jan; 40(1):55-60. PubMed ID: 27697309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
    Furlan JC; Bedard YC; Rosen IB
    J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
    Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
    Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
    Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
    Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of surgical treatment of papillary thyroid carcinoma].
    Zhang ZM; Li ZJ; Tang PZ; Xu ZG; An CM
    Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):779-82. PubMed ID: 22335912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
    Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of locally aggressive well-differentiated thyroid cancer.
    Martins AS; Melo GM; Valério JB; Langner E; Lage HT; Tincani AJ
    Int Surg; 2001; 86(4):213-9. PubMed ID: 12056464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of previous radiation exposure on pathologic features and clinical outcome in patients with thyroid cancer.
    Seaberg RM; Eski S; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):355-9. PubMed ID: 19380356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective treatment of differentiated thyroid carcinoma.
    Gemsenjäger E; Heitz PU; Martina B
    World J Surg; 1997 Jun; 21(5):546-51; discussion 551-2. PubMed ID: 9204746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic outcomes of papillary thyroid carcinomas with tumors more advanced than T1N0M0.
    Lin JD; Lin KJ; Chao TC; Hseuh C; Tsang NM
    Radiother Oncol; 2008 Oct; 89(1):97-104. PubMed ID: 18534700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving postoperative recurrence rates for carcinoma of the thyroid gland.
    McHenry C; Jarosz H; Lawrence AM; Paloyan E
    Surg Gynecol Obstet; 1989 Nov; 169(5):429-34. PubMed ID: 2814754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyroid remnant 131I ablation for papillary and follicular thyroid carcinoma.
    Mazzaferri EL
    Thyroid; 1997 Apr; 7(2):265-71. PubMed ID: 9133698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of childhood and adolescent thyroid carcinoma: long-term follow-up and clinical characteristics.
    Okada T; Sasaki F; Takahashi H; Taguchi K; Takahashi M; Watanabe K; Itoh T; Ota S; Todo S
    Eur J Pediatr Surg; 2006 Feb; 16(1):8-13. PubMed ID: 16544219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases.
    Lin JD; Huang MJ; Juang JH; Chao TC; Huang BY; Chen KW; Chen JY; Li KL; Chen JF; Ho YS
    Thyroid; 1999 Dec; 9(12):1227-35. PubMed ID: 10646663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early recurrence of papillary and follicular thyroid carcinoma predicts a worse outcome.
    Lin JD; Hsueh C; Chao TC
    Thyroid; 2009 Oct; 19(10):1053-9. PubMed ID: 19772423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma.
    Bhattacharyya N
    Otolaryngol Head Neck Surg; 2003 Jan; 128(1):115-23. PubMed ID: 12574769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Draft of the best medical treatment in patients with low-risk thyroid cancer].
    Vlček P; Nováková D; Vejvalka J; Zimák J; Křenek M; Vošmiková K; Smutný S; Bavor P; Astl J; Lukáš J
    Vnitr Lek; 2015 Sep; 61(9):769-77. PubMed ID: 26465275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of tumor capsular invasion in well-differentiated thyroid carcinomas.
    Furlan JC; Bedard YC; Rosen IB
    Am Surg; 2007 May; 73(5):484-91. PubMed ID: 17521005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 71.